THERACLION HUGE BREAKOUT OF Accumulation range : Growth stockTHERACLION HUGE BREAKOUT OF Accumulation range .
This technology is the "new Intuitive surgical"
Huge triangle Accumulation ready for growth stock
Long
THERACLION
No trades
−0.1508 USD
−5.96 M USD
859.45 K USD
41.19 M
About Theraclion SA
Sector
Industry
CEO
Martin Deterre
Website
Headquarters
Malakoff
Founded
2004
IPO date
Apr 25, 2014
Identifiers
2
ISIN FR0010120402
Théraclion SA develops, manufactures, and markets oncological medical equipment. Its products are marketed under the brands of Sonovein, EchoPulse and EPack. EchoPulse is a device used for non-invasive and outpatient treatment of fibroadenoma of the breast and thyroid nodules. EPack is a single-use disposable patented system used for cooling and coupling functions. The company was founded by François Lacoste and Jérôme Lebon on August 5, 2004 and is headquartered in Malakoff, France.
Related stocks
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of TCLIF is 0.3200 USD — it has increased by 188.14 K% in the past 24 hours. Watch THERACLION stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange THERACLION stocks are traded under the ticker TCLIF.
TCLIF reached its all-time high on Feb 10, 2021 with the price of 2.6000 USD, and its all-time low was 0.0002 USD and was reached on Jul 16, 2024. View more price dynamics on TCLIF chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
TCLIF stock is 99.95% volatile and has beta coefficient of 1.77. Track THERACLION stock price on the chart and check out the list of the most volatile stocks — is THERACLION there?
Today THERACLION has the market capitalization of 42.82 M, it has decreased by −0.72% over the last week.
Yes, you can track THERACLION financials in yearly and quarterly reports right on TradingView.
TCLIF net income for the last half-year is −2.99 M USD, while the previous report showed −3.51 M USD of net income which accounts for 14.90% change. Track more THERACLION financial stats to get the full picture.
No, TCLIF doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. THERACLION EBITDA is −7.29 M USD, and current EBITDA margin is −790.63%. See more stats in THERACLION financial statements.
Like other stocks, TCLIF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade THERACLION stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So THERACLION technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating THERACLION stock shows the neutral signal. See more of THERACLION technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.